首页> 外文期刊>Cerebrovascular diseases >Genetic Variants in the Promoter Region of the ALOX5AP Gene and Susceptibility of Ischemic Stroke.
【24h】

Genetic Variants in the Promoter Region of the ALOX5AP Gene and Susceptibility of Ischemic Stroke.

机译:ALOX5AP基因启动子区域的遗传变异和缺血性中风的易感性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Despite accumulating evidence supporting the association between variants of the ALOX5AP gene and atherosclerotic vascular events, the precise mechanism is still unclear. No variants in the coding sequence that lead to amino acid substitution have been found. We investigated genetic variants in the promoter region of the ALOX5AP gene and the association with ischemic stroke in a north Chinese Han population. Methods: 505 cases of ischemic stroke and 500 age- and gender-matched controls of the north Chinese Han population were enrolled. Genetic variants in the promoter region of the ALOX5AP gene were identified by polymerase chain reaction and DNA sequencing. 40 cases and 40 controls were randomly selected and compared for serum leukotriene B(4) (LTB(4)) concentration. The effect on ischemic stroke was evaluated by logistic regression. Results: Three genetic variants were identified, including a mutation (-519 G > A), an insertion and deletion polymorphisms (-581_582 Ins A) and a single nuclear polymorphisms (-946 A > G). Association study showed that the II genotype of -581_582 Ins A was significantly associated with ischemic stroke of a large artery atherosclerosis (OR = 3.50, 95% CI = 1.93-6.36, p = 0.0002) and undetermined etiology (OR = 3.66, 95% CI = 1.92-6.94, p = 0.0006). No significant association was found between the -519 GA genotype (OR = 0.35, 95% CI = 0.02-5.88, p = 0.46), -946 AG genotype (OR = 1.35, 95% CI = 0.85-2.16, p = 0.21) and ischemic stroke. There was no significant difference in serum LTB(4) concentration between cases (n = 40) and controls (n = 40) (log serum LTB(4) of cases vs. controls: 2.67 +/- 0.14 vs. 2.73 +/- 0.18 pg/ml, p = 0.10). However, the serum LTB(4) concentration was significantly higher in participants with the II genotype of -581_582 Ins A (n = 12) than that of participants with the DD genotype (n = 68) (log serum LTB(4) of participants with II genotype vs. DD genotype: 2.82 +/- 0.18 vs. 2.68 +/- 0.15 pg/ml, p = 0.01). Conclusion: The -581_582 Ins A polymorphism might be a novel genetic risk factor for ischemic stroke in a north Chinese Han population. Further studies on molecular mechanism are warranted.
机译:背景:尽管有越来越多的证据支持ALOX5AP基因变异与动脉粥样硬化性血管事件之间的关联,但确切的机制仍不清楚。在编码序列中未发现导致氨基酸取代的变体。我们调查了ALOX5AP基因启动子区域的遗传变异以及与中国北方汉族人群缺血性卒中的关系。方法:招募505例缺血性中风患者和500名年龄和性别相匹配的中国北方汉族人群作为对照。通过聚合酶链反应和DNA测序鉴定了ALOX5AP基因启动子区域的遗传变异。随机选择40例病例和40例对照,并比较血清白三烯B(4)(LTB(4))的浓度。通过逻辑回归评估对缺血性中风的作用。结果:鉴定出三种遗传变异,包括突变(-519 G> A),插入和缺失多态性(-581_582 Ins A)和单核多态性(-946 A> G)。关联研究显示-581_582 Ins A的II基因型与大动脉粥样硬化的缺血性卒中(OR = 3.50,95%CI = 1.93-6.36,p = 0.0002)和病因未明(OR = 3.66,95% CI = 1.92-6.94,p = 0.0006)。 -519 GA基因型(OR = 0.35,95%CI = 0.02-5.88,p = 0.46),-946 AG基因型(OR = 1.35,95%CI = 0.85-2.16,p = 0.21)之间没有发现显着相关性和缺血性中风。病例(n = 40)和对照组(n = 40)之间的血清LTB(4)浓度无显着差异(病例与对照组的log LTB(4)对数:2.67 +/- 0.14 vs. 2.73 +/- 0.18 pg / ml,p = 0.10)。然而,II基因型为-581_582 Ins A的参与者(n = 12)的血清LTB(4)浓度显着高于DD基因型(n = 68)的参与者(log血清LTB(4)) II基因型vs.DD基因型:2.82 +/- 0.18 pg。2.68 +/- 0.15 pg / ml,p = 0.01)。结论:-581_582 Ins A多态性可能是中国北方汉族人群缺血性卒中的一种新的遗传危险因素。有必要进一步研究分子机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号